Articles |
the Vascular Biology Center (A.P., N.M., J.W.R., J.D.C.), the Department of Pharmacology and Toxicology (A.P., N.M., J.W.R., J.D.C.), the Department of Pathology (A.A., R.G.G.), the Department of Pediatrics (D.H.M.), and the Department of Anesthesiology (J.W.R.), Medical College of Georgia, Augusta, and the Armed Forces Institute of Pathology (R.V., F.D.K.), Washington, DC.
Correspondence to Dr John D. Catravas, Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912-2500.
We investigated the effects of monocytes on endothelial cell (EC) ectoenzyme activity. Coculture of human aortic ECs with human monocytes (2x105 monocytes per 2-cm2 well) led to a decrease in EC angiotensin-converting enzyme (ACE) activity (64.5±3.5% of control) but not aminopeptidase N, aminopeptidase P, and 5'-nucleotidase activities. Similar results were obtained using human umbilical vein EChuman monocyte and porcine aortic ECporcine monocyte cocultures. The decrease in ACE activity was monocyte concentration and coculture time dependent, reaching a maximum of 65% decrease in activity at 120 hours. Monocyte-mediated reduction in ACE activity did not require cell to cell contact, since exposure of ECs to conditioned medium from cocultures (CCCM) or from monocyte cultures (MCM) produced a decrease in ACE activity similar to that observed in EC-monocyte cocultures. Exogenously added tumor necrosis factor (TNF)-
and interleukin (IL)-1
, two known secretory products of monocytes, simulated the effects of monocytes on ACE activity. Western blot analysis revealed a decrease in the amount of ACE protein in TNF-
treated and CCCM-treated ECs compared with control ECs. Both TNF-
and IL-1
were present in CCCM and MCM but not EC-conditioned medium. Incubation of the cocultures with a mixture of neutralizing antibodies against TNF-
and IL-1 totally abolished the monocyte-induced decrease in ACE activity. In conclusion, monocytes decrease ACE activity in cultured ECs through the release of cytokines such as TNF-
and IL-1.
Key Words: angiotensin-converting enzyme 5'-nucleotidase surface peptidase tumor necrosis factor-
interleukin-1
This article has been cited by other articles:
![]() |
M. Flesch, A. Hoper, L. Dell'Italia, K. Evans, R. Bond, R. Peshock, A. Diwan, T. A. Brinsa, C.-C. Wei, N. Sivasubramanian, et al. Activation and Functional Significance of the Renin-Angiotensin System in Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor Circulation, August 5, 2003; 108(5): 598 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Itoh, J. Kajikuri, T. Tada, Y. Suzuki, and Y. Mabuchi Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries J. Physiol., May 1, 2003; 548(3): 893 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Todorov, M. Muller, F. Schweda, and A. Kurtz Tumor necrosis factor-alpha inhibits renin gene expression Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2002; 283(5): R1046 - R1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hafizi, J. Wharton, K. Morgan, S. P. Allen, A. H. Chester, J. D. Catravas, J. M. Polak, and M. H. Yacoub Expression of Functional Angiotensin-Converting Enzyme and AT1 Receptors in Cultured Human Cardiac Fibroblasts Circulation, December 8, 1998; 98(23): 2553 - 2559. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |